Status:
COMPLETED
Predictive OCTA Biomarkers After Endoscopic Endonasal Pituitary Surgery
Lead Sponsor:
Federico II University
Conditions:
Pituitary Adenoma
Eligibility:
All Genders
40-65 years
Brief Summary
This study evaluates the structural parameters, by spectral domain optical coherence tomography (OCT), retinal vessel density, using OCT angiography, and visual acuity in patients that received endosc...
Detailed Description
The primary outcome was to detect the changes in visual acuity, retinal structural and vascular features at 48 hours and 1 year after Endoscopic Endonasal Approach for the removal of an intra-suprasel...
Eligibility Criteria
Inclusion
- age older than 40 years
- diagnosis of pituitary adenoma
- treatment-naïve with Endoscopic Endonasal Pituitary Surgery
- absence of other neurological diseases
- absence of vitreoretinal and vascular retinal diseases
Exclusion
- age younger than 40 years
- No diagnosis of pituitary adenoma
- previous treatments with Endoscopic Endonasal Pituitary Surgery
- presence of neurological diseases
- presence of vitreoretinal and vascular retinal diseases
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2020
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04840771
Start Date
June 1 2020
End Date
July 31 2020
Last Update
May 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Naples "Federico II"
Naples, Italy, 80100